PDB Short entry for 1DXO HEADER OXIDOREDUCTASE 12-JAN-00 1DXO TITLE CRYSTAL STRUCTURE OF HUMAN NAD[P]H-QUINONE OXIDOREDUCTASE CO WITH 2,3, TITLE 2 5,6,TETRAMETHYL-P-BENZOQUINONE (DUROQUINONE) AT 2.5 ANGSTROM TITLE 3 RESOLUTION COMPND MOL_ID: 1; COMPND 2 MOLECULE: QUINONE REDUCTASE; COMPND 3 CHAIN: A, B, C, D; COMPND 4 SYNONYM: DT-DIAPHORASE; COMPND 5 EC: 1.6.99.2; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS FLAVOPROTEIN, ROSSMANN FOLD, OXIDOREDUCTASE EXPDTA X-RAY DIFFRACTION AUTHOR M.FAIG,M.A.BIANCHET,S.CHEN,S.WINSKI,D.ROSS,L.M.AMZEL REVDAT 5 05-JUL-17 1DXO 1 REMARK REVDAT 4 12-NOV-14 1DXO 1 HEADER KEYWDS JRNL REMARK REVDAT 4 2 1 VERSN FORMUL SHEET MASTER REVDAT 3 24-FEB-09 1DXO 1 VERSN REVDAT 2 21-OCT-05 1DXO 1 HETATM REVDAT 1 23-APR-00 1DXO 0 JRNL AUTH M.FAIG,M.A.BIANCHET,S.CHEN,S.WINSKI,D.ROSS,P.TALALAY, JRNL AUTH 2 L.M.AMZEL JRNL TITL STRUCTURES OF RECOMBINANT MOUSE AND HUMAN NAD(P)H:QUINONE JRNL TITL 2 OXIDOREDUCTASES:SPECIES COMPARISON AND STRUCTURAL CHANGES JRNL TITL 3 WITH SUBSTRATE BINDING AND RELEASE JRNL REF PROC.NATL.ACAD.SCI.USA V. 97 3177 2000 JRNL REFN ISSN 0027-8424 JRNL PMID 10706635 JRNL DOI 10.1073/PNAS.050585797 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH M.A.BIANCHET,C.FOSTER,M.FAIG,P.TALALAY,L.M.AMZEL REMARK 1 TITL STRUCTURE AND MECHANISM OF CYTOSOLIC QUINONE REDUCTASE REMARK 1 REF BIOCHEM.SOC.TRANS. V. 27 610 1999 REMARK 1 REFN ISSN 0300-5127 REMARK 1 PMID 10917652 REMARK 1 REFERENCE 2 REMARK 1 AUTH C.FOSTER,M.A.BIANCHET,P.TALALAY,Q.ZHAO,L.M.AMZEL REMARK 1 TITL CRYSTAL STRUCTURE OF HUMAN QUINONE REDUCTASE TYPE 2, A REMARK 1 TITL 2 METALLOPROTEIN REMARK 1 REF BIOCHEMISTRY V. 38 9881 1999 REMARK 1 REFN ISSN 0006-2960 REMARK 1 PMID 10433694 REMARK 1 DOI 10.1021/BI990799V REMARK 1 REFERENCE 3 REMARK 1 AUTH R.LI,M.A.BIANCHET,P.TALALAY,L.M.AMZEL REMARK 1 TITL THE THREE-DIMENSIONAL STRUCTURE OF NAD(P)H:QUINONE REMARK 1 TITL 2 REDUCTASE, A FLAVOPROTEIN INVOLVED IN CANCER CHEMOPROTECTION REMARK 1 TITL 3 AND CHEMOTHERAPY: MECHANISM OF TWO-ELECTRON REDUCTION REMARK 1 REF PROC.NATL.ACAD.SCI.USA V. 92 8846 1995 REMARK 1 REFN ISSN 0027-8424 REMARK 1 PMID 7568029 REMARK 1 DOI 10.1073/PNAS.92.19.8846 REMARK 2 REMARK 2 RESOLUTION. 2.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 0.9 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 27.66 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 411877.160 REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 70.8 REMARK 3 NUMBER OF REFLECTIONS : 27730 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.202 REMARK 3 FREE R VALUE : 0.264 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.100 REMARK 3 FREE R VALUE TEST SET COUNT : 2802 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.005 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.50 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.66 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 30.00 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1784 REMARK 3 BIN R VALUE (WORKING SET) : 0.2640 REMARK 3 BIN FREE R VALUE : 0.3050 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 9.60 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 190 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.022 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 8692 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 260 REMARK 3 SOLVENT ATOMS : 105 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 17.90 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 26.10 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.35000 REMARK 3 B22 (A**2) : -1.82000 REMARK 3 B33 (A**2) : 0.46000 REMARK 3 B12 (A**2) : -2.88000 REMARK 3 B13 (A**2) : 3.50000 REMARK 3 B23 (A**2) : -0.02000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.30 REMARK 3 ESD FROM SIGMAA (A) : 0.32 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.39 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.41 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.400 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 21.90 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.930 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.31 REMARK 3 BSOL : 19.00 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : NEWPARAM.DQN REMARK 3 PARAMETER FILE 3 : NEWFAD_XPLOR.PAR REMARK 3 PARAMETER FILE 4 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 5 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : ION.TOP REMARK 3 TOPOLOGY FILE 3 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 4 : DNA-RNA.TOP REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1DXO COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 12-JAN-00. REMARK 100 THE DEPOSITION ID IS D_1290004539. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 8.50 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RUH3R REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : NULL REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 36969 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.500 REMARK 200 RESOLUTION RANGE LOW (A) : 27.660 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 93.8 REMARK 200 DATA REDUNDANCY : 2.500 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.09300 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: OTHER REMARK 200 SOFTWARE USED: CNS 0.9 REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.20 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.37 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PH 8.50 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 9130 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 21280 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -63.7 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 9370 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 21050 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -60.4 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 VAL A 1 CG1 CG2 REMARK 470 VAL B 1 CG1 CG2 REMARK 470 VAL C 1 CG1 CG2 REMARK 470 VAL D 1 CG1 CG2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 123 -46.85 78.59 REMARK 500 TYR A 132 -126.70 45.91 REMARK 500 ASP A 133 -13.41 -47.51 REMARK 500 SER A 191 59.14 28.59 REMARK 500 HIS A 257 53.29 -101.69 REMARK 500 GLU B 123 -44.27 78.94 REMARK 500 TYR B 132 -134.41 49.59 REMARK 500 ASP B 133 -22.90 -39.63 REMARK 500 ILE B 175 -63.38 -102.44 REMARK 500 SER B 191 63.69 29.61 REMARK 500 LEU B 230 35.78 -69.39 REMARK 500 GLN B 233 -74.70 -56.56 REMARK 500 ALA B 234 -1.92 -55.10 REMARK 500 PHE B 236 38.31 36.55 REMARK 500 HIS B 257 53.85 -101.92 REMARK 500 LEU B 259 17.13 56.58 REMARK 500 LYS B 261 -164.05 -105.09 REMARK 500 ASP B 266 50.15 38.19 REMARK 500 ARG B 272 150.39 -48.80 REMARK 500 PHE C 106 27.47 47.41 REMARK 500 GLU C 123 -46.86 78.37 REMARK 500 TYR C 132 -128.12 45.93 REMARK 500 ASP C 133 -19.39 -45.30 REMARK 500 ILE C 175 -65.17 -103.40 REMARK 500 SER C 191 56.56 31.94 REMARK 500 HIS C 257 52.86 -101.18 REMARK 500 LEU C 259 18.42 52.74 REMARK 500 ASP C 266 48.77 37.19 REMARK 500 GLU D 123 -35.52 80.70 REMARK 500 TYR D 126 -167.50 -115.30 REMARK 500 THR D 127 -11.56 -168.10 REMARK 500 TYR D 128 -51.02 64.46 REMARK 500 TYR D 132 -126.01 50.52 REMARK 500 ILE D 175 -64.42 -103.76 REMARK 500 SER D 191 62.69 21.42 REMARK 500 LEU D 230 49.58 -70.87 REMARK 500 SER D 254 -168.78 -161.89 REMARK 500 HIS D 257 54.14 -103.53 REMARK 500 LEU D 259 14.79 54.52 REMARK 500 LYS D 261 -168.47 -100.56 REMARK 500 REMARK 500 REMARK: NULL REMARK 700 REMARK 700 SHEET REMARK 700 DETERMINATION METHOD: DSSP REMARK 700 THERE ARE SEVERAL BIFURCATED SHEETS IN THIS STRUCTURE. REMARK 700 EACH IS REPRESENTED BY TWO SHEETS WHICH HAVE ONE OR MORE REMARK 700 IDENTICAL STRANDS. REMARK 700 SHEETS A AND A1 REPRESENT ONE BIFURCATED SHEET IN CHAIN A REMARK 700 SHEETS B AND B1 REPRESENT ONE BIFURCATED SHEET IN CHAIN D REMARK 700 SHEETS C AND C1 REPRESENT ONE BIFURCATED SHEET IN CHAIN C REMARK 700 SHEETS D AND D1 REPRESENT ONE BIFURCATED SHEET IN CHAIN D REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FAD A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FAD B 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FAD C 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FAD D 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DQN A 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DQN B 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DQN C 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DQN D 302 DBREF 1DXO A 1 273 UNP P15559 DHQU_HUMAN 2 274 DBREF 1DXO B 1 273 UNP P15559 DHQU_HUMAN 2 274 DBREF 1DXO C 1 273 UNP P15559 DHQU_HUMAN 2 274 DBREF 1DXO D 1 273 UNP P15559 DHQU_HUMAN 2 274 SEQRES 1 A 273 VAL GLY ARG ARG ALA LEU ILE VAL LEU ALA HIS SER GLU SEQRES 2 A 273 ARG THR SER PHE ASN TYR ALA MET LYS GLU ALA ALA ALA SEQRES 3 A 273 ALA ALA LEU LYS LYS LYS GLY TRP GLU VAL VAL GLU SER SEQRES 4 A 273 ASP LEU TYR ALA MET ASN PHE ASN PRO ILE ILE SER ARG SEQRES 5 A 273 LYS ASP ILE THR GLY LYS LEU LYS ASP PRO ALA ASN PHE SEQRES 6 A 273 GLN TYR PRO ALA GLU SER VAL LEU ALA TYR LYS GLU GLY SEQRES 7 A 273 HIS LEU SER PRO ASP ILE VAL ALA GLU GLN LYS LYS LEU SEQRES 8 A 273 GLU ALA ALA ASP LEU VAL ILE PHE GLN PHE PRO LEU GLN SEQRES 9 A 273 TRP PHE GLY VAL PRO ALA ILE LEU LYS GLY TRP PHE GLU SEQRES 10 A 273 ARG VAL PHE ILE GLY GLU PHE ALA TYR THR TYR ALA ALA SEQRES 11 A 273 MET TYR ASP LYS GLY PRO PHE ARG SER LYS LYS ALA VAL SEQRES 12 A 273 LEU SER ILE THR THR GLY GLY SER GLY SER MET TYR SER SEQRES 13 A 273 LEU GLN GLY ILE HIS GLY ASP MET ASN VAL ILE LEU TRP SEQRES 14 A 273 PRO ILE GLN SER GLY ILE LEU HIS PHE CYS GLY PHE GLN SEQRES 15 A 273 VAL LEU GLU PRO GLN LEU THR TYR SER ILE GLY HIS THR SEQRES 16 A 273 PRO ALA ASP ALA ARG ILE GLN ILE LEU GLU GLY TRP LYS SEQRES 17 A 273 LYS ARG LEU GLU ASN ILE TRP ASP GLU THR PRO LEU TYR SEQRES 18 A 273 PHE ALA PRO SER SER LEU PHE ASP LEU ASN PHE GLN ALA SEQRES 19 A 273 GLY PHE LEU MET LYS LYS GLU VAL GLN ASP GLU GLU LYS SEQRES 20 A 273 ASN LYS LYS PHE GLY LEU SER VAL GLY HIS HIS LEU GLY SEQRES 21 A 273 LYS SER ILE PRO THR ASP ASN GLN ILE LYS ALA ARG LYS SEQRES 1 B 273 VAL GLY ARG ARG ALA LEU ILE VAL LEU ALA HIS SER GLU SEQRES 2 B 273 ARG THR SER PHE ASN TYR ALA MET LYS GLU ALA ALA ALA SEQRES 3 B 273 ALA ALA LEU LYS LYS LYS GLY TRP GLU VAL VAL GLU SER SEQRES 4 B 273 ASP LEU TYR ALA MET ASN PHE ASN PRO ILE ILE SER ARG SEQRES 5 B 273 LYS ASP ILE THR GLY LYS LEU LYS ASP PRO ALA ASN PHE SEQRES 6 B 273 GLN TYR PRO ALA GLU SER VAL LEU ALA TYR LYS GLU GLY SEQRES 7 B 273 HIS LEU SER PRO ASP ILE VAL ALA GLU GLN LYS LYS LEU SEQRES 8 B 273 GLU ALA ALA ASP LEU VAL ILE PHE GLN PHE PRO LEU GLN SEQRES 9 B 273 TRP PHE GLY VAL PRO ALA ILE LEU LYS GLY TRP PHE GLU SEQRES 10 B 273 ARG VAL PHE ILE GLY GLU PHE ALA TYR THR TYR ALA ALA SEQRES 11 B 273 MET TYR ASP LYS GLY PRO PHE ARG SER LYS LYS ALA VAL SEQRES 12 B 273 LEU SER ILE THR THR GLY GLY SER GLY SER MET TYR SER SEQRES 13 B 273 LEU GLN GLY ILE HIS GLY ASP MET ASN VAL ILE LEU TRP SEQRES 14 B 273 PRO ILE GLN SER GLY ILE LEU HIS PHE CYS GLY PHE GLN SEQRES 15 B 273 VAL LEU GLU PRO GLN LEU THR TYR SER ILE GLY HIS THR SEQRES 16 B 273 PRO ALA ASP ALA ARG ILE GLN ILE LEU GLU GLY TRP LYS SEQRES 17 B 273 LYS ARG LEU GLU ASN ILE TRP ASP GLU THR PRO LEU TYR SEQRES 18 B 273 PHE ALA PRO SER SER LEU PHE ASP LEU ASN PHE GLN ALA SEQRES 19 B 273 GLY PHE LEU MET LYS LYS GLU VAL GLN ASP GLU GLU LYS SEQRES 20 B 273 ASN LYS LYS PHE GLY LEU SER VAL GLY HIS HIS LEU GLY SEQRES 21 B 273 LYS SER ILE PRO THR ASP ASN GLN ILE LYS ALA ARG LYS SEQRES 1 C 273 VAL GLY ARG ARG ALA LEU ILE VAL LEU ALA HIS SER GLU SEQRES 2 C 273 ARG THR SER PHE ASN TYR ALA MET LYS GLU ALA ALA ALA SEQRES 3 C 273 ALA ALA LEU LYS LYS LYS GLY TRP GLU VAL VAL GLU SER SEQRES 4 C 273 ASP LEU TYR ALA MET ASN PHE ASN PRO ILE ILE SER ARG SEQRES 5 C 273 LYS ASP ILE THR GLY LYS LEU LYS ASP PRO ALA ASN PHE SEQRES 6 C 273 GLN TYR PRO ALA GLU SER VAL LEU ALA TYR LYS GLU GLY SEQRES 7 C 273 HIS LEU SER PRO ASP ILE VAL ALA GLU GLN LYS LYS LEU SEQRES 8 C 273 GLU ALA ALA ASP LEU VAL ILE PHE GLN PHE PRO LEU GLN SEQRES 9 C 273 TRP PHE GLY VAL PRO ALA ILE LEU LYS GLY TRP PHE GLU SEQRES 10 C 273 ARG VAL PHE ILE GLY GLU PHE ALA TYR THR TYR ALA ALA SEQRES 11 C 273 MET TYR ASP LYS GLY PRO PHE ARG SER LYS LYS ALA VAL SEQRES 12 C 273 LEU SER ILE THR THR GLY GLY SER GLY SER MET TYR SER SEQRES 13 C 273 LEU GLN GLY ILE HIS GLY ASP MET ASN VAL ILE LEU TRP SEQRES 14 C 273 PRO ILE GLN SER GLY ILE LEU HIS PHE CYS GLY PHE GLN SEQRES 15 C 273 VAL LEU GLU PRO GLN LEU THR TYR SER ILE GLY HIS THR SEQRES 16 C 273 PRO ALA ASP ALA ARG ILE GLN ILE LEU GLU GLY TRP LYS SEQRES 17 C 273 LYS ARG LEU GLU ASN ILE TRP ASP GLU THR PRO LEU TYR SEQRES 18 C 273 PHE ALA PRO SER SER LEU PHE ASP LEU ASN PHE GLN ALA SEQRES 19 C 273 GLY PHE LEU MET LYS LYS GLU VAL GLN ASP GLU GLU LYS SEQRES 20 C 273 ASN LYS LYS PHE GLY LEU SER VAL GLY HIS HIS LEU GLY SEQRES 21 C 273 LYS SER ILE PRO THR ASP ASN GLN ILE LYS ALA ARG LYS SEQRES 1 D 273 VAL GLY ARG ARG ALA LEU ILE VAL LEU ALA HIS SER GLU SEQRES 2 D 273 ARG THR SER PHE ASN TYR ALA MET LYS GLU ALA ALA ALA SEQRES 3 D 273 ALA ALA LEU LYS LYS LYS GLY TRP GLU VAL VAL GLU SER SEQRES 4 D 273 ASP LEU TYR ALA MET ASN PHE ASN PRO ILE ILE SER ARG SEQRES 5 D 273 LYS ASP ILE THR GLY LYS LEU LYS ASP PRO ALA ASN PHE SEQRES 6 D 273 GLN TYR PRO ALA GLU SER VAL LEU ALA TYR LYS GLU GLY SEQRES 7 D 273 HIS LEU SER PRO ASP ILE VAL ALA GLU GLN LYS LYS LEU SEQRES 8 D 273 GLU ALA ALA ASP LEU VAL ILE PHE GLN PHE PRO LEU GLN SEQRES 9 D 273 TRP PHE GLY VAL PRO ALA ILE LEU LYS GLY TRP PHE GLU SEQRES 10 D 273 ARG VAL PHE ILE GLY GLU PHE ALA TYR THR TYR ALA ALA SEQRES 11 D 273 MET TYR ASP LYS GLY PRO PHE ARG SER LYS LYS ALA VAL SEQRES 12 D 273 LEU SER ILE THR THR GLY GLY SER GLY SER MET TYR SER SEQRES 13 D 273 LEU GLN GLY ILE HIS GLY ASP MET ASN VAL ILE LEU TRP SEQRES 14 D 273 PRO ILE GLN SER GLY ILE LEU HIS PHE CYS GLY PHE GLN SEQRES 15 D 273 VAL LEU GLU PRO GLN LEU THR TYR SER ILE GLY HIS THR SEQRES 16 D 273 PRO ALA ASP ALA ARG ILE GLN ILE LEU GLU GLY TRP LYS SEQRES 17 D 273 LYS ARG LEU GLU ASN ILE TRP ASP GLU THR PRO LEU TYR SEQRES 18 D 273 PHE ALA PRO SER SER LEU PHE ASP LEU ASN PHE GLN ALA SEQRES 19 D 273 GLY PHE LEU MET LYS LYS GLU VAL GLN ASP GLU GLU LYS SEQRES 20 D 273 ASN LYS LYS PHE GLY LEU SER VAL GLY HIS HIS LEU GLY SEQRES 21 D 273 LYS SER ILE PRO THR ASP ASN GLN ILE LYS ALA ARG LYS HET FAD A 301 53 HET DQN A 302 12 HET FAD B 301 53 HET DQN B 302 12 HET FAD C 301 53 HET DQN C 302 12 HET FAD D 301 53 HET DQN D 302 12 HETNAM FAD FLAVIN-ADENINE DINUCLEOTIDE HETNAM DQN DUROQUINONE FORMUL 5 FAD 4(C27 H33 N9 O15 P2) FORMUL 6 DQN 4(C10 H12 O2) FORMUL 13 HOH *105(H2 O) HELIX 1 1 SER A 16 LYS A 32 1 17 HELIX 2 2 SER A 51 ASP A 54 5 4 HELIX 3 3 ASP A 61 PHE A 65 5 5 HELIX 4 4 GLN A 66 GLY A 78 1 13 HELIX 5 5 SER A 81 ALA A 94 1 14 HELIX 6 6 PRO A 109 PHE A 120 1 12 HELIX 7 7 MET A 131 GLY A 135 5 5 HELIX 8 8 SER A 151 SER A 156 5 6 HELIX 9 9 ASP A 163 SER A 173 1 11 HELIX 10 10 LEU A 176 GLY A 180 5 5 HELIX 11 11 SER A 191 THR A 195 5 5 HELIX 12 12 PRO A 196 LEU A 211 1 16 HELIX 13 13 GLU A 212 GLU A 217 5 6 HELIX 14 14 PRO A 224 LEU A 227 5 4 HELIX 15 15 LYS A 239 LYS A 247 1 9 HELIX 16 16 SER B 16 LYS B 32 1 17 HELIX 17 17 LEU B 41 ASN B 45 1 5 HELIX 18 18 SER B 51 ASP B 54 5 4 HELIX 19 19 GLN B 66 GLY B 78 1 13 HELIX 20 20 SER B 81 ALA B 94 1 14 HELIX 21 21 PRO B 109 PHE B 120 1 12 HELIX 22 22 THR B 127 MET B 131 5 5 HELIX 23 23 MET B 131 GLY B 135 5 5 HELIX 24 24 SER B 151 SER B 156 5 6 HELIX 25 25 ASP B 163 SER B 173 1 11 HELIX 26 26 LEU B 176 GLY B 180 5 5 HELIX 27 27 SER B 191 THR B 195 5 5 HELIX 28 28 PRO B 196 GLU B 212 1 17 HELIX 29 29 ASN B 213 GLU B 217 5 5 HELIX 30 30 PRO B 224 LEU B 227 5 4 HELIX 31 31 LYS B 239 LYS B 247 1 9 HELIX 32 32 SER C 16 LYS C 32 1 17 HELIX 33 33 SER C 51 ASP C 54 5 4 HELIX 34 34 GLN C 66 GLY C 78 1 13 HELIX 35 35 SER C 81 ALA C 94 1 14 HELIX 36 36 PRO C 109 PHE C 120 1 12 HELIX 37 37 THR C 127 MET C 131 5 5 HELIX 38 38 MET C 131 GLY C 135 5 5 HELIX 39 39 SER C 151 SER C 156 5 6 HELIX 40 40 ASP C 163 SER C 173 1 11 HELIX 41 41 LEU C 176 GLY C 180 5 5 HELIX 42 42 SER C 191 THR C 195 5 5 HELIX 43 43 PRO C 196 GLU C 212 1 17 HELIX 44 44 ASN C 213 GLU C 217 5 5 HELIX 45 45 PRO C 224 LEU C 227 5 4 HELIX 46 46 LYS C 239 LYS C 247 1 9 HELIX 47 47 SER D 16 LYS D 32 1 17 HELIX 48 48 SER D 51 ASP D 54 5 4 HELIX 49 49 ASP D 61 PHE D 65 5 5 HELIX 50 50 GLN D 66 GLY D 78 1 13 HELIX 51 51 SER D 81 ALA D 94 1 14 HELIX 52 52 PRO D 109 PHE D 120 1 12 HELIX 53 53 MET D 131 GLY D 135 5 5 HELIX 54 54 SER D 151 SER D 156 5 6 HELIX 55 55 ASP D 163 SER D 173 1 11 HELIX 56 56 LEU D 176 GLY D 180 5 5 HELIX 57 57 SER D 191 THR D 195 5 5 HELIX 58 58 PRO D 196 GLU D 212 1 17 HELIX 59 59 ASN D 213 GLU D 217 5 5 HELIX 60 60 PRO D 224 LEU D 227 5 4 HELIX 61 61 LYS D 239 LYS D 247 1 9 SHEET 1 AA 5 GLU A 35 ASP A 40 0 SHEET 2 AA 5 ARG A 4 LEU A 9 1 O ALA A 5 N VAL A 37 SHEET 3 AA 5 LEU A 96 PRO A 102 1 O LEU A 96 N LEU A 6 SHEET 4 AA 5 LYS A 141 THR A 147 1 O LYS A 141 N VAL A 97 SHEET 5 AA 5 GLN A 187 THR A 189 -1 O GLN A 187 N ILE A 146 SHEET 1 AB 5 GLU A 35 ASP A 40 0 SHEET 2 AB 5 ARG A 4 LEU A 9 1 O ALA A 5 N VAL A 37 SHEET 3 AB 5 LEU A 96 PRO A 102 1 O LEU A 96 N LEU A 6 SHEET 4 AB 5 LYS A 141 THR A 147 1 O LYS A 141 N VAL A 97 SHEET 5 AB 5 GLN A 182 VAL A 183 1 O GLN A 182 N ALA A 142 SHEET 1 AC 2 GLN A 187 THR A 189 0 SHEET 2 AC 2 LYS A 141 THR A 147 -1 O LEU A 144 N GLN A 187 SHEET 1 BA 5 GLU B 35 ASP B 40 0 SHEET 2 BA 5 ARG B 4 LEU B 9 1 O ALA B 5 N VAL B 37 SHEET 3 BA 5 LEU B 96 PRO B 102 1 O LEU B 96 N LEU B 6 SHEET 4 BA 5 LYS B 141 THR B 147 1 O LYS B 141 N VAL B 97 SHEET 5 BA 5 GLN B 187 THR B 189 -1 O GLN B 187 N ILE B 146 SHEET 1 BB 5 GLU B 35 ASP B 40 0 SHEET 2 BB 5 ARG B 4 LEU B 9 1 O ALA B 5 N VAL B 37 SHEET 3 BB 5 LEU B 96 PRO B 102 1 O LEU B 96 N LEU B 6 SHEET 4 BB 5 LYS B 141 THR B 147 1 O LYS B 141 N VAL B 97 SHEET 5 BB 5 GLN B 182 VAL B 183 1 O GLN B 182 N ALA B 142 SHEET 1 BC 2 GLN B 187 THR B 189 0 SHEET 2 BC 2 LYS B 141 THR B 147 -1 O LEU B 144 N GLN B 187 SHEET 1 CA 5 GLU C 35 ASP C 40 0 SHEET 2 CA 5 ARG C 4 LEU C 9 1 O ALA C 5 N VAL C 37 SHEET 3 CA 5 LEU C 96 PRO C 102 1 O LEU C 96 N LEU C 6 SHEET 4 CA 5 LYS C 141 THR C 147 1 O LYS C 141 N VAL C 97 SHEET 5 CA 5 GLN C 187 THR C 189 -1 O GLN C 187 N ILE C 146 SHEET 1 CB 5 GLU C 35 ASP C 40 0 SHEET 2 CB 5 ARG C 4 LEU C 9 1 O ALA C 5 N VAL C 37 SHEET 3 CB 5 LEU C 96 PRO C 102 1 O LEU C 96 N LEU C 6 SHEET 4 CB 5 LYS C 141 THR C 147 1 O LYS C 141 N VAL C 97 SHEET 5 CB 5 GLN C 182 VAL C 183 1 O GLN C 182 N ALA C 142 SHEET 1 CC 2 GLN C 187 THR C 189 0 SHEET 2 CC 2 LYS C 141 THR C 147 -1 O LEU C 144 N GLN C 187 SHEET 1 DA 5 GLU D 35 ASP D 40 0 SHEET 2 DA 5 ARG D 4 LEU D 9 1 O ALA D 5 N VAL D 37 SHEET 3 DA 5 LEU D 96 PRO D 102 1 O LEU D 96 N LEU D 6 SHEET 4 DA 5 LYS D 141 THR D 147 1 O LYS D 141 N VAL D 97 SHEET 5 DA 5 GLN D 187 THR D 189 -1 O GLN D 187 N ILE D 146 SHEET 1 DB 5 GLU D 35 ASP D 40 0 SHEET 2 DB 5 ARG D 4 LEU D 9 1 O ALA D 5 N VAL D 37 SHEET 3 DB 5 LEU D 96 PRO D 102 1 O LEU D 96 N LEU D 6 SHEET 4 DB 5 LYS D 141 THR D 147 1 O LYS D 141 N VAL D 97 SHEET 5 DB 5 GLN D 182 VAL D 183 1 O GLN D 182 N ALA D 142 SHEET 1 DC 2 GLN D 187 THR D 189 0 SHEET 2 DC 2 LYS D 141 THR D 147 -1 O LEU D 144 N GLN D 187 SITE 1 AC1 25 HIS A 11 THR A 15 SER A 16 PHE A 17 SITE 2 AC1 25 ASN A 18 ALA A 20 PRO A 102 LEU A 103 SITE 3 AC1 25 GLN A 104 TRP A 105 PHE A 106 THR A 147 SITE 4 AC1 25 THR A 148 GLY A 149 GLY A 150 TYR A 155 SITE 5 AC1 25 ILE A 192 ARG A 200 LEU A 204 DQN A 302 SITE 6 AC1 25 HOH A2021 HOH A2022 GLN C 66 TYR C 67 SITE 7 AC1 25 PRO C 68 SITE 1 AC2 23 HIS B 11 THR B 15 SER B 16 PHE B 17 SITE 2 AC2 23 ASN B 18 ALA B 20 PRO B 102 LEU B 103 SITE 3 AC2 23 GLN B 104 TRP B 105 PHE B 106 THR B 147 SITE 4 AC2 23 THR B 148 GLY B 149 GLY B 150 TYR B 155 SITE 5 AC2 23 ILE B 192 ARG B 200 LEU B 204 DQN B 302 SITE 6 AC2 23 ASN D 64 GLN D 66 TYR D 67 SITE 1 AC3 22 GLN A 66 TYR A 67 HIS C 11 THR C 15 SITE 2 AC3 22 SER C 16 PHE C 17 ASN C 18 ALA C 20 SITE 3 AC3 22 PRO C 102 LEU C 103 GLN C 104 TRP C 105 SITE 4 AC3 22 PHE C 106 THR C 147 THR C 148 GLY C 149 SITE 5 AC3 22 GLY C 150 TYR C 155 ILE C 192 ARG C 200 SITE 6 AC3 22 LEU C 204 DQN C 302 SITE 1 AC4 22 GLN B 66 TYR B 67 PRO B 68 HIS D 11 SITE 2 AC4 22 THR D 15 SER D 16 PHE D 17 ASN D 18 SITE 3 AC4 22 ALA D 20 PRO D 102 LEU D 103 GLN D 104 SITE 4 AC4 22 TRP D 105 PHE D 106 THR D 147 THR D 148 SITE 5 AC4 22 GLY D 149 GLY D 150 TYR D 155 ILE D 192 SITE 6 AC4 22 ARG D 200 LEU D 204 SITE 1 AC5 7 TRP A 105 GLY A 149 FAD A 301 TYR C 126 SITE 2 AC5 7 TYR C 128 PHE C 178 HOH C2017 SITE 1 AC6 8 FAD B 301 HOH B2020 GLY D 122 TYR D 126 SITE 2 AC6 8 PHE D 178 DQN D 302 HOH D2007 HOH D2011 SITE 1 AC7 7 TYR A 126 TYR A 128 PHE A 178 HOH A2014 SITE 2 AC7 7 TRP C 105 FAD C 301 HOH C2023 SITE 1 AC8 4 GLY B 149 HIS B 194 DQN B 302 PHE D 232 CRYST1 55.579 56.912 97.755 76.24 76.73 86.33 P 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017992 -0.001154 -0.004087 0.00000 SCALE2 0.000000 0.017607 -0.004156 0.00000 SCALE3 0.000000 0.000000 0.010799 0.00000